Walgreens Boots Alliance Schedules Fiscal 2016 First Quarter Earnings Announcement for 7 January 2016

Guía de Regalos

DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal
2016 first quarter earnings results at 7 a.m. Eastern time Thursday, 7
January 2016, followed by a one-hour conference call with Walgreens
Boots Alliance management beginning at 8:30 a.m. Eastern time.

The conference call will be simulcast through the Walgreens Boots
Alliance investor relations website at: http://investor.walgreensbootsalliance.com.
A replay of the conference call will be archived on the website for 12
months after the call.

The replay also will be available from 11:30 a.m. Eastern time, 7
January 2016 through 14 January 2016, by calling 855-859-2056 within the
USA and Canada, or 404-537-3406 outside the USA and Canada, using replay
code 93731993.

Notes to Editors:

About Walgreens Boots Alliance

Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led,
health and wellbeing enterprise.

The company was created through the combination of Walgreens and
Alliance Boots in December 2014, bringing together two leading companies
with iconic brands, complementary geographic footprints, shared values
and a heritage of trusted health care services through pharmaceutical
wholesaling and community pharmacy care, dating back more than 100 years.

The company employs over 370,000* people and has a presence in more than
25* countries; it is the largest retail pharmacy, health and daily
living destination in the USA and Europe. Including its equity method
investments, Walgreens Boots Alliance is a global leader in
pharmacy-led, health and wellbeing retail with over 13,100* stores in
11* countries. The company includes one of the largest global
pharmaceutical wholesale and distribution networks with over 350*
distribution centers delivering to more than 200,000** pharmacies,
doctors, health centers and hospitals each year in 19* countries. In
addition, Walgreens Boots Alliance is one of the world’s largest
purchasers of prescription drugs and many other health and wellbeing
products.

Its portfolio of retail and business brands includes Walgreens, Duane
Reade, Boots and Alliance Healthcare, as well as increasingly global
health and beauty product brands, such as No7, Botanics, Liz Earle and
Soap & Glory. More company information is available at www.walgreensbootsalliance.com.

* As at 31 August 2015 including equity method investments

** For 12 months ended 31 August 2015 including equity method
investments

Cautionary Note Regarding Forward-Looking Statements: All
statements in this release and related conference call and webcast that
are not historical are forward-looking statements made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements are not guarantees of future
performance and involve risks, assumptions and uncertainties, including
those described in Item 1A (Risk Factors) of our Form 10-K for the
fiscal year ending 31 August 2015, which is incorporated herein by
reference, and in other documents that we file or furnish with the
Securities and Exchange Commission. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially. These forward-looking
statements speak only as of the date they are made. Except to the extent
required by law, we do not undertake, and expressly disclaim, any duty
or obligation to update publicly any forward-looking statement after the
date of this release, whether as a result of new information, future
events, changes in assumptions or otherwise.

Contacts

Walgreens Boots Alliance
Media Relations
USA / Michael
Polzin
+1 847 315 2935
or
International / Laura Vergani
+44
(0)207 980 8585
or
Investor Relations
Gerald
Gradwell and Ashish Kohli
+1 847 315 2922